CARDIO DIAGNOSTICS INC.

Profile

Company Names

CARDIO DIAGNOSTICS INC.

Addresses

400 N ABERDEEN ST., SUITE 900, CHICAGO, IL 60642

400 N ABERDEEN ST, SUITE 900,, CHICAGO, IL 60642

2500 CROSSPARK ROAD, W245, CORALVILLE, IA 52241

Phone Numbers

6317965412

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$19,936,036.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-05-23 
$6,486,036.00 
$6,486,036.00 
$0.00 
Equity 
2
2021-07-01 
$6,725,000.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2021-04-06 
$6,725,000.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MEESHANTHINI 
 
DOGAN 
EXECUTIVE OFFICER, DIRECTOR
CARDIO DIAGNOSTICS INC.   |  CARDIO DIAGNOSTICS HOLDINGS, INC.
WARREN 
 
HOSSEINION 
DIRECTOR
APOLLO MEDICAL HOLDINGS, INC.   |  CLINIGENCE HOLDINGS, INC.   |  CLINIGENCE HOLDINGS, INC.   |  IGAMBIT, INC.   |  CARDIO DIAGNOSTICS INC.   |  NUTEX HEALTH, INC.   |  VESICOR THERAPEUTICS, INC.
ELISA 
 
LUQMAN 
EXECUTIVE OFFICER
CLINIGENCE HOLDINGS, INC.   |  IGAMBIT, INC.   |  CARDIO DIAGNOSTICS INC.   |  NUTEX HEALTH, INC.   |  CARDIO DIAGNOSTICS HOLDINGS, INC.
ELISA 
MICHAEL 
LUQMAN 
EXECUTIVE OFFICER, DIRECTOR
CARDIO DIAGNOSTICS INC.
ROBERT 
 
PHILIBERT 
EXECUTIVE OFFICER, DIRECTOR
CARDIO DIAGNOSTICS INC.   |  CARDIO DIAGNOSTICS HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-23 
2022-05-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-06 
2022-05-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-01 
2021-12-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
EMERSON EQUITY LLC
130032